Testosterone therapy may lower HbA1c for men with type 2 diabetes

Key takeaways:

Data from a real-world audit revealed that men with type 2 diabetes using testosterone therapy lowered HbA1c by 0.5 percentage points at 6 months.

The audit is continuing to enroll centers and acquire more data.

Men with type 2 diabetes have significant improvements in HbA1c and hypogonadism symptoms as soon as 3 months after starting testosterone therapy, according to real-world data presented at the Androgen Society annual meeting.

As many as 40% of men with type 2 diabetes have testosterone deficiency, according to T. Hugh Jones, MD, consultant physician and endocrinologist at Barnsley Hospital, honorary professor of andrology at the University of Sheffield and honorary consultant endocrinologist at Royal Hallamshire Hospital in Sheffield, U.K. He said several rando